Fluconazole susceptibility testing of Candida inconspicua clinical isolates: Comparison of four methods [1]

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 2, 2005, Pages 275-276

  Majoros, L ^a   Kardos, G ^a   Szabo B ^a   Kovacs M ^b   Maraz A ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Institute of Entrepreneurship and Innovation   (Hungary)

Author keywords

Broth microdilution; C. inconspicua; Etest; Fungitest; NCCLS

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; CANDIDA; CANDIDA INCONSPICUA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITALIZATION; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; LETTER; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN;

CANDIDA; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 14744293039     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh539     Document Type: Letter

References (6)

1. Majoros, L., Kardos, G., Belák, Á. et al. (2003). Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures. Journal of Clinical Microbiology 41, 5250-3.
2. Barchiesi, F., Tortorano, A. M., Di Francesco, F. M. et al. (1999). In vitro activity of five antifungal agents against uncommon clinical isolates of Candida species. Journal of Antimicrobial Chemotherapy 43, 295-9.
3. Pfaller, M. A., Diekema, D. J., Messer, S. A. et al. (2003). In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. Journal of Clinical Microbiology 41, 78-83.
4. Swoboda-Kopec, E., Kawecki, D., Wroblewska, M. et al. (2003). Epidemiology and susceptibility to antifungal agents of fungi isolated from clinical specimens from patients hospitalized in the Department of General and Liver Surgery of the Medical University of Warsaw. Transplantation Proceedings 35, 2298-303.
5. National Committee for Clinical Laboratory Standards. (2002). Reference Method for Broth Dilution Testing of Yeasts - Second Edition: Approved Standard M27-A2. NCCLS, Villanova, PA, USA.
6. Baily, G. G., Moore, C. B., Essayag, S. M. et al. (1997). Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clinical Infectious Diseases 25, 161-3.